Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mahendra Chemicals is an Indian pharmaceutical company specializing in the manufacture of Active Pharmaceutical Ingredients (APIs) and fine chemical intermediates. Established in 1976 and headquartered in Ahmedabad, the company has built a strong reputation for producing high-quality anticonvulsants and antidiabetic agents. Their core product portfolio includes Phenytoin, Phenytoin Sodium, and Gliclazide, serving both domestic and international markets. Mahendra Chemicals operates state-of-the-art manufacturing facilities that comply with global regulatory standards, providing essential components for various therapeutic formulations. The company focuses on chemical synthesis and process optimization to maintain its position as a reliable supplier in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mahendra Chemicals.